igf 1 lr3 nasal spray igf 1 lr3 vs tesamorelin
Description
200300 mcg per day in standard use, once daily over a 48 week course
Du, Q., Luu, P
PJ can reduce hyperlipidemia, serum BUN, and 24-h UTP in diabetic mice by modulating unsaturated FAs, glycerophospholipid metabolism, and purine metabolism
It is a selective growth hormone secretagogue receptor agonist, meaning it stimulates GH release through a different receptor pathway than GHRH
